From CureVac’s IPO Hauls In $213M as Key mRNA COVID-19 Vaccine Test Nears:

old-university-town-tuebingen-germany-picture-id870412300

old-university-town-tuebingen-germany-picture-id870412300—

Image: iStock/Nikolaj Alexander
https://www.istockphoto.com/portfolio/nikolajalexander?assettype=image&mediatype=photography&sort=best

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Sponsored · Special Report
As the Commercial Real Estate Market Slumps, Look for a More Tenant-Friendly Future
Hyperinflation in rents is over
Hughes Marino

From Our Editors · Special Report
Xcelerating Life Sciences San Francisco: Special Report
The AI, Big Data, and R&D Boom

Xconomy on Demand

We offer a number of ways to subscribe for free!